Vaccines
Follow analytical innovations driving vaccine development and quality.
Articles
Dr Arnaud Delobel of Quality Assistance discusses vaccine QC strategies, from platform-specific analytical methods to validation challenges, emerging technologies, and regulatory considerations.
Articles
Explore how N-glycan profiling is becoming essential in the characterization of viral vectors, based on workflows from Agilent’s streamlined glycan analysis platform.
Articles
Explore how analytical scientists use cutting-edge tools to ensure vaccine stability, from formulation to cold-chain distribution.
Articles
Explore how high-throughput screening, bioinformatics, and flow cytometry accelerate the antigen discovery process for effective vaccine design.
